Recruiting PHASE2 INTERVENTIONAL 1-arm NCT06553365

Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors

An Open, Single-Arm Phase II Study Evaluating the Efficacy and Safety of FCN-159 in Selected NF2-associated Nerve Sheath Tumors

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions Nerve Sheath Tumor

Interventions FCN-159

Updated 2 times since 2024 Last updated: Jul 25, 2025 Started: Aug 15, 2024 Primary completion: Jul 31, 2026 Completion: Jul 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Nerve Sheath Tumor and is currently actively recruiting participants. Cancer Institute and Hospital, Chinese Academy of Medical Sciences leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Aug 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Data source: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China